Skip to content

Clinical trials

Completed Metabolic Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: Belgium Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20131
20142
20151
20171
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Eli Lilly and Company1
Erasme University Hospital1
Ionis Pharmaceuticals, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases10
Hyperlipidemias5
Lipid Metabolism Disorders5
Dyslipidemias3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Glucose Metabolism Disorders2
Hypercholesterolemia2
Hypertriglyceridemia2
Acute Coronary Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.